Orchestra BioMed Holdings Statistics
Total Valuation
OBIO has a market cap or net worth of $101.53 million. The enterprise value is $68.09 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OBIO has 38.31 million shares outstanding. The number of shares has increased by 6.17% in one year.
| Current Share Class | 38.31M |
| Shares Outstanding | 38.31M |
| Shares Change (YoY) | +6.17% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 21.72% |
| Float | 17.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 34.37 |
| Forward PS | 30.00 |
| PB Ratio | 6.02 |
| P/TBV Ratio | 6.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 23.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.35, with a Debt / Equity ratio of 0.98.
| Current Ratio | 3.35 |
| Quick Ratio | 3.23 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -231.65 |
Financial Efficiency
Return on equity (ROE) is -179.12% and return on invested capital (ROIC) is -93.36%.
| Return on Equity (ROE) | -179.12% |
| Return on Assets (ROA) | -60.70% |
| Return on Invested Capital (ROIC) | -93.36% |
| Return on Capital Employed (ROCE) | -157.93% |
| Revenue Per Employee | $41,229 |
| Profits Per Employee | -$947,371 |
| Employee Count | 70 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.74% in the last 52 weeks. The beta is 0.66, so OBIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -43.74% |
| 50-Day Moving Average | 3.40 |
| 200-Day Moving Average | 5.03 |
| Relative Strength Index (RSI) | 43.61 |
| Average Volume (20 Days) | 968,817 |
Short Selling Information
The latest short interest is 1.23 million, so 3.21% of the outstanding shares have been sold short.
| Short Interest | 1.23M |
| Short Previous Month | 541,410 |
| Short % of Shares Out | 3.21% |
| Short % of Float | 7.08% |
| Short Ratio (days to cover) | 1.51 |
Income Statement
In the last 12 months, OBIO had revenue of $2.89 million and -$66.32 million in losses. Loss per share was -$1.77.
| Revenue | 2.89M |
| Gross Profit | 2.67M |
| Operating Income | -68.80M |
| Pretax Income | -51.64M |
| Net Income | -66.32M |
| EBITDA | -68.48M |
| EBIT | -68.80M |
| Loss Per Share | -$1.77 |
Full Income StatementBalance Sheet
The company has $49.88 million in cash and $16.44 million in debt, giving a net cash position of $33.44 million or $0.87 per share.
| Cash & Cash Equivalents | 49.88M |
| Total Debt | 16.44M |
| Net Cash | 33.44M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 16.86M |
| Book Value Per Share | 0.44 |
| Working Capital | 36.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$54.06 million and capital expenditures -$393,000, giving a free cash flow of -$54.45 million.
| Operating Cash Flow | -54.06M |
| Capital Expenditures | -393,000 |
| Free Cash Flow | -54.45M |
| FCF Per Share | -$1.42 |
Full Cash Flow StatementMargins
| Gross Margin | 92.58% |
| Operating Margin | -2,383.89% |
| Pretax Margin | -2,297.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |